Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 1.10 | -1.54 | 13.36 |
| 6M | 1.25 | 1.40 | 44.88 |
| 1Y | 16.86 | 5.97 | 121.64 |
| 3Y | 0.00 | 14.35 | 230.94 |
HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹2,031 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.09. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundMotilal Oswal Digital India Fund Growth | 0 | 730.43 CR | 2.34 |
| This FundUnion Innovation & Opportunities Fund Growth | 0 | 1052.97 CR | 2.21 |
| This FundHDFC Pharma and Healthcare Fund Growth | 0 | 2030.81 CR | 2.09 |
| This FundICICI Prudential PSU Equity Fund Growth | 0 | 2021.84 CR | 2.08 |
| This FundNippon India Taiwan Equity Fund Growth | 3 | 448.04 CR | 2.42 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundMotilal Oswal Digital India Fund Growth | -5.7489 | 0 |
| This FundUnion Innovation & Opportunities Fund Growth | 7.047 | 0 |
| This FundHDFC Pharma and Healthcare Fund Growth | 16.8645 | 0 |
| This FundICICI Prudential PSU Equity Fund Growth | 19.4185 | 105.7656 |
| This FundNippon India Taiwan Equity Fund Growth | 118.586 | 217.4449 |